Harbin Gloria Pharmaceuticals Co., Ltd (002437.SZ)
CNY 2.36
(-1.26%)
CNY 2.36
(-1.26%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.47 Billion CNY | -38.24% |
| 2022 | 2.38 Billion CNY | 3.16% |
| 2021 | 2.31 Billion CNY | 2.37% |
| 2020 | 2.26 Billion CNY | -38.98% |
| 2019 | 3.7 Billion CNY | -9.28% |
| 2018 | 4.08 Billion CNY | 90.34% |
| 2017 | 2.14 Billion CNY | 22.67% |
| 2016 | 1.74 Billion CNY | 3.28% |
| 2015 | 1.69 Billion CNY | 41.21% |
| 2014 | 1.19 Billion CNY | 18.93% |
| 2013 | 1 Billion CNY | 122.99% |
| 2012 | 452.47 Million CNY | 70.28% |
| 2011 | 265.72 Million CNY | -13.22% |
| 2010 | 306.21 Million CNY | 26.22% |
| 2009 | 242.6 Million CNY | 37.93% |
| 2008 | 175.89 Million CNY | 63.24% |
| 2007 | 107.75 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 312.1 Million CNY | 451.06% |
| 2024 Q3 | 329.21 Million CNY | 0.95% |
| 2024 Q2 | 326.11 Million CNY | 4.49% |
| 2023 Q1 | 534.32 Million CNY | -0.04% |
| 2023 Q3 | 481.32 Million CNY | -19.46% |
| 2023 Q4 | -88.9 Million CNY | -118.47% |
| 2023 FY | 1.47 Billion CNY | -38.24% |
| 2023 Q2 | 597.65 Million CNY | 11.85% |
| 2022 Q2 | 615.93 Million CNY | 5.13% |
| 2022 Q1 | 585.87 Million CNY | 1.54% |
| 2022 Q4 | 534.55 Million CNY | -18.06% |
| 2022 Q3 | 652.36 Million CNY | 5.91% |
| 2022 FY | 2.38 Billion CNY | 3.16% |
| 2021 Q2 | 634.11 Million CNY | 19.67% |
| 2021 FY | 2.31 Billion CNY | 2.37% |
| 2021 Q3 | 574.62 Million CNY | -9.38% |
| 2021 Q1 | 529.88 Million CNY | -17.97% |
| 2021 Q4 | 576.97 Million CNY | 0.41% |
| 2020 Q1 | 394.63 Million CNY | -50.41% |
| 2020 FY | 2.26 Billion CNY | -38.98% |
| 2020 Q3 | 617.1 Million CNY | 2.12% |
| 2020 Q4 | 645.93 Million CNY | 4.67% |
| 2020 Q2 | 604.27 Million CNY | 53.12% |
| 2019 FY | 3.7 Billion CNY | -9.28% |
| 2019 Q1 | 920.2 Million CNY | -20.62% |
| 2019 Q2 | 1.11 Billion CNY | 20.72% |
| 2019 Q3 | 880.16 Million CNY | -20.77% |
| 2019 Q4 | 795.81 Million CNY | -9.58% |
| 2018 Q2 | 989.44 Million CNY | 13.59% |
| 2018 Q3 | 1.06 Billion CNY | 7.79% |
| 2018 Q1 | 871.04 Million CNY | 2.7% |
| 2018 Q4 | 1.15 Billion CNY | 8.69% |
| 2018 FY | 4.08 Billion CNY | 90.34% |
| 2017 Q1 | 350.55 Million CNY | -32.11% |
| 2017 FY | 2.14 Billion CNY | 22.67% |
| 2017 Q3 | 539.64 Million CNY | 32.14% |
| 2017 Q4 | 848.17 Million CNY | 57.17% |
| 2017 Q2 | 408.37 Million CNY | 16.5% |
| 2016 Q4 | 516.38 Million CNY | 17.64% |
| 2016 Q2 | 421.68 Million CNY | 13.07% |
| 2016 Q1 | 372.94 Million CNY | -20.05% |
| 2016 FY | 1.74 Billion CNY | 3.28% |
| 2016 Q3 | 438.96 Million CNY | 4.1% |
| 2015 FY | 1.69 Billion CNY | 41.21% |
| 2015 Q3 | 421.67 Million CNY | -10.89% |
| 2015 Q2 | 473.18 Million CNY | 42.06% |
| 2015 Q1 | 333.09 Million CNY | -2.96% |
| 2015 Q4 | 466.48 Million CNY | 10.62% |
| 2014 Q1 | 192.65 Million CNY | -27.27% |
| 2014 FY | 1.19 Billion CNY | 18.93% |
| 2014 Q3 | 298.43 Million CNY | -18.37% |
| 2014 Q2 | 365.58 Million CNY | 89.76% |
| 2014 Q4 | 343.25 Million CNY | 15.02% |
| 2013 Q2 | 337.16 Million CNY | 141.78% |
| 2013 Q3 | 267.44 Million CNY | -20.68% |
| 2013 Q4 | 264.9 Million CNY | -0.95% |
| 2013 FY | 1 Billion CNY | 122.99% |
| 2013 Q1 | 139.45 Million CNY | -18.89% |
| 2012 Q2 | 130.27 Million CNY | 81.26% |
| 2012 Q4 | 171.92 Million CNY | 119.29% |
| 2012 FY | 452.47 Million CNY | 70.28% |
| 2012 Q1 | 71.87 Million CNY | -14.43% |
| 2012 Q3 | 78.4 Million CNY | -39.82% |
| 2011 Q1 | 44.78 Million CNY | -59.51% |
| 2011 Q2 | 85.39 Million CNY | 90.65% |
| 2011 Q3 | 51.55 Million CNY | -39.63% |
| 2011 Q4 | 83.99 Million CNY | 62.93% |
| 2011 FY | 265.72 Million CNY | -13.22% |
| 2010 Q4 | 110.61 Million CNY | 63.07% |
| 2010 Q2 | 86.61 Million CNY | 110.45% |
| 2010 Q3 | 67.82 Million CNY | -21.69% |
| 2010 FY | 306.21 Million CNY | 26.22% |
| 2010 Q1 | 41.15 Million CNY | -55.3% |
| 2009 Q4 | 92.07 Million CNY | 65.37% |
| 2009 FY | 242.6 Million CNY | 37.93% |
| 2009 Q2 | 62.28 Million CNY | 91.23% |
| 2009 Q1 | 32.56 Million CNY | 0.0% |
| 2009 Q3 | 55.67 Million CNY | -10.6% |
| 2008 FY | 175.89 Million CNY | 63.24% |
| 2007 FY | 107.75 Million CNY | 0.0% |